Overview

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

Status:
RECRUITING
Trial end date:
2029-03-31
Target enrollment:
Participant gender:
Summary
ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Phase:
PHASE3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
tirabrutinib